Corcept Therapeutics, Inc. (CORT)
112.79
-2.13
(-1.85%)
USD |
NASDAQ |
Sep 11, 16:00
112.80
+0.01
(+0.01%)
After-Hours: 20:00
Corcept Therapeutics Price : 112.79 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 115.22 | 117.84 | 109.30 | 112.79 | 1.282M |
| Sep 10, 2026 | 114.42 | 116.99 | 113.20 | 114.92 | 683008.0 |
| Sep 09, 2026 | 114.20 | 117.50 | 113.77 | 115.70 | 572049.0 |
| Sep 08, 2026 | 108.87 | 115.28 | 108.25 | 113.98 | 1.046M |
| Sep 04, 2026 | 110.59 | 112.13 | 109.26 | 111.62 | 604557.0 |
| Sep 03, 2026 | 110.38 | 114.61 | 109.43 | 112.80 | 611215.0 |
| Sep 02, 2026 | 113.38 | 115.78 | 108.72 | 110.43 | 960830.0 |
| Sep 01, 2026 | 113.92 | 115.85 | 111.13 | 113.38 | 1.112M |
| Aug 31, 2026 | 113.64 | 114.52 | 111.23 | 113.35 | 636565.0 |
| Aug 28, 2026 | 117.14 | 118.67 | 112.97 | 113.88 | 917931.0 |
| Aug 27, 2026 | 119.25 | 121.30 | 116.70 | 116.93 | 642409.0 |
| Aug 26, 2026 | 122.57 | 123.64 | 119.74 | 119.80 | 981086.0 |
| Aug 25, 2026 | 124.89 | 126.38 | 122.00 | 123.57 | 981693.0 |
| Aug 24, 2026 | 120.56 | 124.14 | 119.17 | 123.24 | 1.013M |
| Aug 21, 2026 | 121.48 | 123.44 | 120.56 | 122.25 | 656445.0 |
| Aug 20, 2026 | 118.11 | 121.72 | 116.31 | 121.05 | 787410.0 |
| Aug 19, 2026 | 119.37 | 121.11 | 118.37 | 119.02 | 859697.0 |
| Aug 18, 2026 | 116.60 | 119.95 | 116.60 | 118.10 | 804025.0 |
| Aug 17, 2026 | 115.00 | 117.49 | 114.38 | 117.17 | 541103.0 |
| Aug 14, 2026 | 110.61 | 114.90 | 110.08 | 114.47 | 728923.0 |
| Aug 13, 2026 | 112.53 | 113.00 | 110.23 | 110.51 | 740456.0 |
| Aug 12, 2026 | 110.89 | 114.00 | 110.60 | 112.18 | 662994.0 |
| Aug 11, 2026 | 114.13 | 114.71 | 111.66 | 111.86 | 699951.0 |
| Aug 10, 2026 | 110.84 | 114.63 | 110.05 | 114.23 | 1.256M |
| Aug 07, 2026 | 108.25 | 110.79 | 108.08 | 110.77 | 769043.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1115.70 |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 84.95 |
| Liquidia Corp. | 66.74 |
| Merck & Co., Inc. | 143.93 |
| Pfizer Inc. | 27.72 |
Price Related Metrics
| PE Ratio | 269.38 |
| PS Ratio | 15.68 |
| Price to Book Value | 17.25 |
| Price to Free Cash Flow | 121.87 |
| Earnings Yield | 0.37% |
| Market Cap | 12.17B |
| Operating PE Ratio | 2034.42 |
| Normalized PE Ratio | 269.38 |